Phreesia Inc
NYSE:PHR
Phreesia Inc
NYSE:PHR
Price:
21.37 USD
-2.69%
Market Closed
Updated:
May 12, 2024
EV/S
Enterprise Value to Sales
Enterprise Value to Sales
3.1
Current
5
Median
2.5
Industry
Lower
than median
Higher
than industry value
Enterprise Value to Sales (EV/S) ratio is a valuation multiple that compares the enterprise value (EV) of a company to its revenues. The EV/S multiple gives investors a quantifiable metric of how to value a company based on its sales while taking account of both the company's equity and debt.
EV/S
=3.1
Enterprise Value
/
1.1B
Revenue
356.3m
All Countries
| Market Cap | EV/S | ||||
|---|---|---|---|---|---|
| US |
|
Phreesia Inc
NYSE:PHR
|
1.2B USD | 3.1 | |
| US |
|
Veeva Systems Inc
NYSE:VEEV
|
32.9B USD | 12.2 | |
| US |
|
Cerner Corp
NASDAQ:CERN
|
27.9B USD | 4.9 | |
| US |
|
Change Healthcare Inc
NASDAQ:CHNG
|
9B USD | 3.8 | |
| AU |
|
Pro Medicus Ltd
ASX:PME
|
12B AUD | 81.4 | |
| JP |
|
M3 Inc
TSE:2413
|
1.1T JPY | 4 | |
| US |
|
Inspire Medical Systems Inc
NYSE:INSP
|
5B USD | 6.9 | |
| US |
|
Doximity Inc
NYSE:DOCS
|
4.4B USD | 7.8 | |
| SE |
|
Sectra AB
STO:SECT B
|
45.4B SEK | 27.3 | |
| US |
|
Evolent Health Inc
NYSE:EVH
|
2.8B USD | 1.6 | |
| US |
|
Vocera Communications Inc
NYSE:VCRA
|
2.8B USD | 11.3 |
EV/S Forward Multiples
Forward EV/S multiple is a version of the EV/S ratio that uses forecasted revenue for the EV/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
EV/S
2.6
2-Years Forward
EV/S
2.2
3-Years Forward
EV/S
1.9
You don't have any saved screeners yet
